News

Lactobacillus reuteri Protectis reduced diarrhoea in children
A double-blind, placebo-controlled study of 494 children showed that supplementation of Lactobacillus reuteri Protectis significantly reduced episodes of diarrhoea. Lactobacillus reuteri Protectis was particularly effective in children with lower nutritional status. Another probiotic strain, which was also tested, was without effect.
BioGaia extends collaboration with Nestlé
Since 2008, BioGaia and Nestlé have collaborated in the field of infant nutrition products. The parties have now signed agreements to extend this collaboration. These agreements are of significant strategic value for BioGaia since they not only involve an extended close collaboration with Nestlé but also generate a greater financial freedom for BioGaia to further invest in its own brand, develop its own new products, research around new indications and increase the distribution of BioGaia-branded products.
BioGaia AB : Year-end report 2011
BioGaia AB Year-end report 2011 (Figures in brackets refer to the same period of last year)2011-     Net sales reached SEK 315.0 million (236.0), an increase of SEK 79.0 million (33%).
BioGaia AB : Interim report 1 January - 30 September 2011
BioGaia AB Interim report 1 January - 30 September 2011(Figures in brackets refer to the same period of last year)Interim period, 1 January - 30 September 2011-    Net sales reached SEK 232.6 million (173.3), an increase of SEK 59.3 million (34%).
Interim report 1 January - 30 September 2011
BioGaia signs new exclusive distribution agreement with Victus
BioGaia signs new exclusive distribution agreement with Victus The agreement refers to sales of BioGaia's Probiotic drops and tablets in Venezuela and Puerto Rico under the BioGaia brand. Launches are estimated to take place during 2012.
BioGaia signs agreement with the largest pharmaceutical company in the Philippines for its probiotic chewable tablets
BioGaia signs agreement with the largest pharmaceutical company in the Philippines for its probiotic chewable tablets  
BioGaia signs exclusive agreement with Fleet Laboratories in U.S.
BioGaia has signed an agreement with Fleet Laboratories for the exclusive rights to sell BioGaia's Probiotic tablets with strawberry flavour in the U.S. and its territories (excluding Puerto Rico). Launch is planned to first quarter 2012.  
Interim report 1 January - 30 June 2011
BioGaia AB Interim report 1 January - 30 June 2011
BioGaia AB Interim report 1 January - 30 June 2011(Figures in brackets refer to the same period of last year)Interim period, 1 January - 30 June 2011-    Net sales reached SEK 159.5 million (124.4), an increase of SEK 35.1 million (28%).